Live
- AAP's 'Pujari Granthi Samman Yojana' under fire from both BJP, Congress
- 7,500 CCTV cameras in Bengaluru to monitor New Year celebrations: K'taka Minister
- Jeju Air crash stokes fears of tarnished image for budget carriers
- Stable political scenario, favourable policy, infra push to drive Indian economy in 2025
- Kerala is ours, falling Hindu population a concern, says Nitesh Rane
- Former MLA Patnam Narender Receives Police Notice in Assault Case
- Telangana Four-Wheelers Association Offers Free Transportation for New Year Celebrations
- Increased Cold Wave in Telugu States: Patancheru Records 13.2 Degrees
- Case filed against Perni Nani in ration rice case
- India targets $1 billion banana exports as sea route trial proves successful
Scientist finds non-invasive method of cancer detection
Scientist finds non-invasive method of cancer detection
During the study, it was shown that circulating cell free DNA could be used as an effective marker to evaluate tumour burden in the patients, both in untreated and treated individuals. It also shows that during concurrent chemo-radiotherapy, ccfDNA load disappeared and after six months of follow up, appeared back due to distant metastasis.
Dr Samrendra Kumar Singh, assistant professor, School of Biotechnology in the Institute of Science, Banaras Hindu University (BHU), has found a non-invasive method to diagnose cervical cancer in patients.
His findings have been published in the 'Journal of Cancer Research and Therapeutics (JCRT)'. The study finds a cost-effective and specific method for early detection, treatment monitoring, the status of residual disease and distant tumour metastasis in cervical cancer patients. The study was undertaken in collaboration with the department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, BHU.
He said that the sensitivity and specificity of this method and short half-life of ccfDNA makes this method reliable and potent as an affordable and real-time biomarker for detecting tumour burden in cervical carcinoma patients. The study has also shown a way to follow up prognostic outcomes of medication/surgery by using blood samples from cancer patients.
